Reduction of Topical Anesthetic Onset Time Using Ultrasound

Phase 4

Completed

• Conditions: Pain

• Registration Number: NCT00126932
• Lead Sponsor: Connecticut Children's Medical Center

Brief Summary

Children ages 3-7 who are undergoing blood drawing receive either standard care, topical medicine for numbing (LMX4), or the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The child's pain with the blood drawing procedure is evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Study Completion: 2004-12
• Study First Submitted: 2005-08-03
• Study First Submitted QC: 2005-08-03
• Study First Posted: 2005-08-05
• Status Verified: 2007-12
• Last Update Submitted: 2007-12-20
• Last Update Posted: 2007-12-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• Ages 3-7, requiring venipuncture

Exclusion Criteria

• Emergent procedure
• Allergy to lidocaine or sodium lauryl sulfate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
pain associated with venipuncture

Secondary Outcome Measures

Name	Time	Method
safety
skin effects
tolerability

Trial Locations

Locations (1)

CT Children's Medical Center; 🇺🇸 Hartford, Connecticut, United States